Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GATA2 haploinsufficiency accelerates EVI1-driven leukemogenesis
S. Katayama, Mikiko Suzuki, Ayaka Yamaoka, et al.
Blood (2017) Vol. 130, Iss. 7, pp. 908-919
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Gata2 as a Crucial Regulator of Stem Cells in Adult Hematopoiesis and Acute Myeloid Leukemia
Juan Bautista Menendez-Gonzalez, Milica Vukovic, Ali Abdelfattah, et al.
Stem Cell Reports (2019) Vol. 13, Iss. 2, pp. 291-306
Open Access | Times Cited: 65
Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia
Sophie Ottema, Roger Mulet‐Lazaro, H. Berna Beverloo, et al.
Blood (2020) Vol. 136, Iss. 2, pp. 224-234
Open Access | Times Cited: 54
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol
Álex Bataller, Ana Garrido, Francesca Guijarro, et al.
Blood Advances (2021) Vol. 6, Iss. 4, pp. 1193-1206
Open Access | Times Cited: 39
EVI1 drives leukemogenesis through aberrant ERG activation
Johannes Schmoellerl, Inês Amorim Monteiro Barbosa, Martina Minnich, et al.
Blood (2022) Vol. 141, Iss. 5, pp. 453-466
Closed Access | Times Cited: 25
Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)
Guillaume Richard‐Carpentier, Caitlin R. Rausch, Koji Sasaki, et al.
Haematologica (2023)
Open Access | Times Cited: 14
Constructing and deconstructing GATA2-regulated cell fate programs to establish developmental trajectories
Kirby D. Johnson, Daniel Conn, Evgenia Shishkova, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 11
Open Access | Times Cited: 33
Enhancer dysfunction in leukemia
Anand S. Bhagwat, Bin Lü, Christopher R. Vakoc
Blood (2018) Vol. 131, Iss. 16, pp. 1795-1804
Open Access | Times Cited: 36
Blood disease–causing and –suppressing transcriptional enhancers: general principles and GATA2 mechanisms
Emery H. Bresnick, Kirby D. Johnson
Blood Advances (2019) Vol. 3, Iss. 13, pp. 2045-2056
Open Access | Times Cited: 32
Tumor suppressor function of Gata2 in acute promyelocytic leukemia
Casey Katerndahl, Olivia R. S. Rogers, Ryan B. Day, et al.
Blood (2021) Vol. 138, Iss. 13, pp. 1148-1161
Open Access | Times Cited: 25
Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors
Daisuke Ikeda, SungGi Chi, Satoshi Uchiyama, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5950-5950
Open Access | Times Cited: 18
Mechanisms of enhancer‐driven oncogene activation
Joyce Vriend, Ruud Delwel, Dorien Pastoors
International Journal of Cancer (2025)
Open Access
The demographic characteristics and prognosis of acute myeloid leukemia with t(3;3)/inv(3) in the united states: a SEER-based study
Xianfeng Ouyang, Xia Wu, Su Hu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Acute Myeloid Leukaemia
FRACP Barbara J. Bain MB BS, FRCP Mike Leach MB ChB
(2024), pp. 141-270
Closed Access | Times Cited: 3
Oncogenic Enhancers in Leukemia
Roger Mulet‐Lazaro, Ruud Delwel
Blood Cancer Discovery (2024) Vol. 5, Iss. 5, pp. 303-317
Closed Access | Times Cited: 3
EVI1 and GATA2 misexpression induced by inv(3)(q21q26) contribute to megakaryocyte-lineage skewing and leukemogenesis
Ayaka Yamaoka, Mikiko Suzuki, S. Katayama, et al.
Blood Advances (2020) Vol. 4, Iss. 8, pp. 1722-1736
Open Access | Times Cited: 21
Identification of therapeutic targets of the hijacked super-enhancer complex in EVI1-rearranged leukemia
Sandra Kiehlmeier, Mahmoud‐Reza Rafiee, Ali Bakr, et al.
Leukemia (2021) Vol. 35, Iss. 11, pp. 3127-3138
Open Access | Times Cited: 20
Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activation
Juehua Gao, Sandeep Gurbuxani, Taylor Zak, et al.
Genes Chromosomes and Cancer (2021) Vol. 61, Iss. 2, pp. 71-80
Closed Access | Times Cited: 15
Aberrant GATA2 Activation in Pediatric B-Cell Acute Lymphoblastic Leukemia
Han Wang, Bowen Cui, Huiying Sun, et al.
Frontiers in Pediatrics (2022) Vol. 9
Open Access | Times Cited: 8
EVI1 exerts distinct roles in AML via ERG and cyclin D1 promoting a chemoresistant and immune-suppressive environment
Yosuke Masamoto, Akira Chiba, Hideaki Mizuno, et al.
Blood Advances (2022) Vol. 7, Iss. 8, pp. 1577-1593
Open Access | Times Cited: 8
Reduced-intensity conditioning is effective for allogeneic hematopoietic stem cell transplantation in infants with MECOM-associated syndrome
Masahiro Irie, Tetsuya Niihori, Tomohiro Nakano, et al.
International Journal of Hematology (2022) Vol. 117, Iss. 4, pp. 598-606
Open Access | Times Cited: 8
EVI1-mediated Programming of Normal and Malignant Hematopoiesis
Susanne Lux, Michael D. Milsom
HemaSphere (2023) Vol. 7, Iss. 10, pp. e959-e959
Open Access | Times Cited: 4
Rapid progression to AML in a patient with germline GATA2 mutation and acquired NRAS Q61K mutation
Lisa J. McReynolds, Yubo Zhang, Yanqin Yang, et al.
Leukemia Research Reports (2019) Vol. 12, pp. 100176-100176
Open Access | Times Cited: 11
From Genotype to Phenotype: How Enhancers Control Gene Expression and Cell Identity in Hematopoiesis
Roger Mulet‐Lazaro, Ruud Delwel
HemaSphere (2023) Vol. 7, Iss. 11, pp. e969-e969
Open Access | Times Cited: 4
A newly identified gene Ahed plays essential roles in murine haematopoiesis
Ritsuko Nakai, Takafumi Yokota, Masahiro Tokunaga, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Acute myeloid leukemia (AML) with chromosome 3 inversion: biology, management, and clinical outcome
Abdulrahman Alhajahjeh, Jan Philipp Bewersdorf, Rebecca P. Bystrom, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 11, pp. 1541-1551
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top